Table 1.
Frequency of STX11 loss in non-Hodgkin’s lymphoma
| Histological subgroup | n (%) |
|---|---|
| PTTL | 4/6 (67) |
| PTCL-NOS | 4/51 (8) |
| ATL | 3/62 (5) |
| Acute type | 3/35 (9) |
| Chronic type | 0/27 (0) |
| AITL† | 0/39 (0) |
| ALCL‡ | 3/74 (3) |
| PTCL | 14/232 (6) |
| NK-cell lymphoma | 7/35 (20) |
| DLBCL | 28/118 (24) |
| Mantle cell lymphoma | 3/21 (14) |
| Follicular lymphoma | 8/80 (10) |
| Burkitt lymphoma | 2/26 (8) |
| MALT lymphoma | 1/31 (3) |
| Total | 63/543 (12) |
†
This was determined using the published result reported by Thorns et al.35 ‡This was determined using the published result reported by Salaverria et al.36 AITL, angioimmunoblastic lymphoma; ALCL, anaplastic large cell lymphoma; ATL, adult T-cell leukemia/lymphoma; DLBCL, diffuse large B-cell lymphoma; MALT lymphoma, mucosa-associated lymphoid tissue lymphoma; PTCL, peripheral T-cell lymohomas; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; PTTL, primary thyroid T-cell lymphoma.